Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Supports molecular mimicry in Chagas cardiomyopathy; leaves open whether anti-P antibodies drive progression or warrant targeted testing.
Levitus et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: